Using transdermal estrogen to improve bone health in women with anorexia nervosa
Official title: Transdermal Estrogen for the Treatment of Bone Loss in Women With Anorexia Nervosa
Run by University of Pittsburgh · NCT03875378 · Data updated 2026-11-12
This study is testing if a skin patch with estrogen can help improve bone health in women aged 20 to 45 who have anorexia nervosa.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 19 Years to 45 Years |
| Sex | Women only |
| Enrollment | 66 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | August 28, 2020 |
| Main results expected | August 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT03875378 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 19 to 45 with a diagnosis of anorexia nervosa, low body weight, amenorrhea, and low bone mineral density.
✕Probably not a fit
Patients with conditions affecting bone metabolism or a history of certain medical issues, such as clotting disorders or breast cancer, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, placebo-controlled study aims to evaluate the effectiveness of transdermal estrogen in increasing bone mineral density (BMD) in adult women aged 20 to 45 with anorexia nervosa. Anorexia nervosa is associated with significant bone loss, leading to increased fracture risk, and this study seeks to address the chronic bone health issues faced by these patients. Participants will receive either transdermal estrogen or a placebo over an 18-month period, with the primary outcome being changes in BMD. The study is crucial for developing effective treatments for the long-term complications of anorexia nervosa.
Why it matters
Potential benefit: If successful, this treatment could significantly improve bone health and reduce fracture risk in women suffering from anorexia nervosa.
How similar studies have gone: While there is limited research specifically on transdermal estrogen for this population, studies on estrogen's role in bone health suggest potential benefits, making this approach promising yet somewhat novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Female 2. 19-45 years of age 3. DSM-5 psychiatric criteria for anorexia nervosa 4. \<85% of ideal body weight as defined by the 1983 Metropolitan Life Insurance Height and Weight Tables 5. Amenorrhea 6. T-score of \< -1.0 at spine or hip Exclusion Criteria: 1. Diseases known to affect bone metabolism, including untreated thyroid dysfunction, vitamin D deficiency, Cushing's syndrome, diabetes mellitus or renal insufficiency (eGFR \< 60) 2. Personal history of venous or arterial clot 3. History of stroke or myocardial infarction 4. History of hypercoagulable disorder 5. Personal history or history of a first-degree relative with breast cancer 6. History of hereditary angioedema 7. Any medication known to affect bone metabolism, including systemic glucocorticoids within three months of the baseline visit, depot medroxyprogesterone within 6 months of the baseline visit, oral bisphosphonates within one year of the baseline visit or IV bisphosphonates within three years of the baseline visit 8. Bone fracture within the prior 12 months 9. Serum potassium \< 3.0 meq/L, serum ALT \> 3 times the upper limit of normal or Hemoglobin \< 10 g/dL 10. Fasting serum triglyceride level \> 150 mg/dL 11. Pregnant or breastfeeding (or desiring pregnancy within the next 18 months) 12. Active substance abuse 13. Elevated PTH level 14. 25-OH vitamin D level \< 20 ng/mL 15. Low phosphorus level
Where it's running
-
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Pouneh Fazeli, MD — University of Pittsburgh
- Study coordinator: Pouneh Fazeli, MD
- Email: pkfazeli@pitt.edu
- Phone: 412-586-9700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Specialist Supportive Clinical Management for teens with anorexia or atypical anorexia
This study tests a teen-focused SSCM approach to help 13-17 year-olds with anorexia nervosa or atypical anorexia nervosa when other treatments haven’t worked or can’t be used.
-
Identifying Signatures of Gut Interoception in Functional Dyspepsia and Anorexia Nervosa
This study tests how the gut-brain connection works in people with functional dyspepsia or anorexia nervosa using brain imaging.
-
Online FBT-DBT for Caregivers of Teens with Anorexia Nervosa
This online program tests a combination of family-based and DBT skills to help caregivers of teens with anorexia nervosa manage stress and improve family support.
-
Eating Disorder Dynamic Intervention
A digital program is tested to help adults with eating disorders by sending real-time, personalized coping tips based on smartphone surveys and sensor data.
-
Hormone and metabolic patterns in hypothalamus-like brain cells from people with anorexia nervosa
This study will test whether hypothalamic-like neurons made from adult women with long-standing anorexia nervosa respond differently to metabolic hormones than neurons from healthy women.
-
Narrative medicine workshops to support teens and young adults with anorexia nervosa (virtual)
This program tests whether a six-week series of narrative medicine workshops can help 16–25-year-olds with anorexia nervosa express themselves, reflect, and build resilience.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.